| 1 |
34466729 | High-throughput drug screening models of mature adipose tissues which replicate the physiology of patients' Body Mass Index (BMI). | 2022 Jan |
1 |
| 2 |
35059243 | The forgotten type 2 diabetes mellitus medicine: rosiglitazone. | 2022 Jan |
2 |
| 3 |
33115283 | Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer. | 2021 Mar |
5 |
| 4 |
33382528 | Enhancement of select cognitive domains with rosiglitazone implicates dorsal hippocampus circuitry sensitive to PPARγ agonism in an Alzheimer's mouse model. | 2021 Feb |
1 |
| 5 |
33502690 | Preclinical and clinical evaluation of a new method to assess cardiac insulin resistance using nuclear imaging. | 2021 Jan 27 |
1 |
| 6 |
33609419 | Impact of diabetes on promoting the growth of breast cancer. | 2021 May |
1 |
| 7 |
33643468 | Towards an Insulin Resistant Adipose Model on a Chip. | 2021 Feb |
1 |
| 8 |
32344313 | Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? | 2020 Jul |
1 |
| 9 |
32766764 | Peroxisome proliferator-activated receptor gamma expression along the male genital system and its role in male fertility. | 2020 Sep 1 |
1 |
| 10 |
33036752 | Rosiglitazone ameliorates skeletal muscle insulin resistance by decreasing free fatty acids release from adipocytes. | 2020 Dec 17 |
4 |
| 11 |
30551378 | A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models. | 2019 Jan |
1 |
| 12 |
30964707 | Effect of PPARγ agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes mellitus and coronary artery disease: a 1-yr randomized study. | 2019 Jul 1 |
1 |
| 13 |
31073335 | Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes. | 2019 |
1 |
| 14 |
31129998 | Understanding Contemporary Use of Thiazolidinediones. | 2019 Jun |
1 |
| 15 |
31270305 | Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: The roles of insulin signaling in SH-SY5Y cell line. | 2019 |
3 |
| 16 |
28986164 | Circulating ApoJ is closely associated with insulin resistance in human subjects. | 2018 Jan |
1 |
| 17 |
29573098 | Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized study. | 2018 Jul |
2 |
| 18 |
30119183 | Ameliorative effects of indomethacin at different concentrations on endothelial insulin resistance through two distinct pathways. | 2018 Oct |
2 |
| 19 |
30278161 | New insights into molecular mechanisms of rosiglitazone in monotherapy or combination therapy against cancers. | 2018 Dec 25 |
2 |
| 20 |
28337819 | PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-β and TNF-α in mononuclear cells by insulin-sensitizing drugs. | 2017 Jul |
1 |
| 21 |
28506962 | Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in db/db Mice. | 2017 Aug |
1 |
| 22 |
28790390 | Involvement of Insulin Signaling Disturbances in Bisphenol A-Induced Alzheimer's Disease-like Neurotoxicity. | 2017 Aug 8 |
1 |
| 23 |
28952262 | [Piperine regulates glucose metabolism disorder in HepG2 cells of insulin resistance models via targeting upstream target of AMPK signaling pathway]. | 2017 Feb |
1 |
| 24 |
29183107 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2017 Nov 29 |
1 |
| 25 |
29228555 | Circulating betatrophin is associated with insulin resistance in humans: cross-sectional and interventional studies in vivo and in vitro. | 2017 Nov 14 |
1 |
| 26 |
26998551 | Alizarin Complexone Functionalized Mesoporous Silica Nanoparticles: A Smart System Integrating Glucose-Responsive Double-Drugs Release and Real-Time Monitoring Capabilities. | 2016 Apr 6 |
1 |
| 27 |
27268145 | PPARγ signaling and emerging opportunities for improved therapeutics. | 2016 Sep |
1 |
| 28 |
27620069 | Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetes. | 2016 Nov |
1 |
| 29 |
25621136 | Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis. | 2015 Jan |
3 |
| 30 |
25789586 | Damage to vascular endothelial cells by high insulin levels is associated with increased expression of ChemR23, and attenuated by PPAR-gamma agonist, rosiglitazone. | 2015 |
1 |
| 31 |
26548081 | Interaction of mouse intestinal P-glycoprotein with oral antidiabetic drugs and its inhibitors. | 2015 Sep |
1 |
| 32 |
24492466 | Insulin regulates the novel adipokine adipolin/CTRP12: in vivo and ex vivo effects. | 2014 Apr |
1 |
| 33 |
24577463 | Long-term metformin usage and cognitive function among older adults with diabetes. | 2014 |
1 |
| 34 |
24622797 | Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy. | 2014 Jul |
1 |
| 35 |
24636967 | Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis. | 2014 Nov |
1 |
| 36 |
26317056 | Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients. | 2014 Oct-Dec |
5 |
| 37 |
23081744 | Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes. | 2013 Jan |
2 |
| 38 |
23593417 | Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial. | 2013 |
3 |
| 39 |
23913730 | The expression of FTO in human adipose tissue is influenced by fat depot, adiposity, and insulin sensitivity. | 2013 Jun |
1 |
| 40 |
23983807 | Electroacupuncture and rosiglitazone combined therapy as a means of treating insulin resistance and type 2 diabetes mellitus: a randomized controlled trial. | 2013 |
1 |
| 41 |
23991629 | Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant α-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus. | 2013 Oct |
1 |
| 42 |
24029780 | Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study. | 2013 |
2 |
| 43 |
24094981 | Resistin, an adipokine, may affect the improvement of insulin sensitivity in the metabolic syndrome patient treated with metformin. | 2013 Dec |
1 |
| 44 |
24117256 | Endogenous hydrogen sulfide in perivascular adipose tissue: role in the regulation of vascular tone in physiology and pathology. | 2013 Nov |
2 |
| 45 |
21483233 | Rosiglitazone attenuates tumor necrosis factor-α-induced protein-tyrosine phosphatase-1B production in HepG2 cells. | 2012 Jan |
1 |
| 46 |
21970545 | A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome. | 2012 Apr |
3 |
| 47 |
22036866 | Why do anti-inflammatory therapies fail to improve insulin sensitivity? | 2012 Feb |
2 |
| 48 |
22374753 | Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology. | 2012 May 1 |
1 |
| 49 |
22424623 | Association of a SLC30A8 genetic variant with monotherapy of repaglinide and rosiglitazone effect in newly diagnosed type 2 diabetes patients in China. | 2012 Feb |
1 |
| 50 |
22468731 | Rosiglitazone prior authorization safety policy: a cohort study. | 2012 Apr |
2 |